Sign in
Taking people in United KingdomNo phase

Mapping Lymph Drainage Paths in People With Throat Cancer

Tests a new imaging and surgical method to find sentinel lymph nodes in throat cancer.

Key facts

Who runs it
University College, London
Where
London, United KingdomSee the 2 sites
Trial code
Registry title
Lymphatic Mapping Of Oropharyngeal Cancer
Status
Recruiting
People taking part
150 people, planned
Started
7 Jul 2022
Expected to end
Jan 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Imaging procedure
  • Surgical procedure
Record updated
19 September 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with newly diagnosed oropharyngeal cancer and a cancer spread to lymph nodes on one side of the neck.

Age
18 years or older
Sex
All sexes can join
Disease stage
New diagnosis of oropharyngeal cancer, any part of the oropharynx, HPV positive or negative. Lymph node spread on one side only: AJCC TNM8 clinical stage N1-N2b if P16 negative, N1 if P16 positive.
Earlier treatment
No earlier radiotherapy or surgery to the neck.
Biomarker or test result
HPV status can be either; P16 status sets the allowed lymph node stage (N1-N2b if P16 negative, N1 if P16 positive).

Main reasons for not taking part

  • Suspicious lymph nodes on both sides of the neck on imaging
  • Previous radiotherapy or surgery to the neck
  • A second primary oropharyngeal tumour
  • Distant metastasis, for example in the lung or bone
  • Pregnancy or breastfeeding

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adults aged 18 or over
  • New diagnosis of OPC - all anatomical subsites and HPV status accepted
  • Unilateral metastatic nodes equating to AJCC TNM8 clinical staging N1-N2b for P16 negative and N1 for P16 positive patients

Who cannot take part

  • Previous radiotherapy or surgery to the neck
  • Allergy to lymphatic tracers
  • Suspicious bilateral nodes on imaging
  • Second primary oropharyngeal tumours
  • Distant metastasis (e.g. lung, bone)
  • Pregnancy and lactation
  • Inability to give informed consent

This trial is currently available in United Kingdom.

  • St. George's University Hospitals NHS Foundation TrustLondon, United KingdomContact: Enyi OfoTaking people
  • University College HospitalLondon, United KingdomContact: Clare SchillingTaking people

About the trial

What the trial wants to find out

A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.

The 2 groups in the trial

  • Imaging PhaseTreatment being tested

    During routine examination under anaesthetic 4 x peritumoural injection of investigator's choice of 99mTc-human albumin colloidal particles or Lymphoseek (lymphatic mapping tracer) followed by freehand SPECT scan

    Treatment: Imaging procedure

  • Surgical PhaseTreatment being tested

    Excision of contralateral nodes identified on imaging \*(fhSPECT or SPECT/CT\*) during routine examination under anaesthetic. Serial sectioning of excised (sentinel) nodes to identify micrometastasis.

    Treatment: Surgical procedure

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective, Multi-Centre, Phase II Validation Study for a Lymphatic Imaging Protocol in Establishing Drainage Patterns in Patients With Oropharyngeal Cancer
Plain-language title
Mapping Lymph Drainage Paths in People With Throat CancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
19 September 2024